» Authors » Charles Frenette

Charles Frenette

Explore the profile of Charles Frenette including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 1329
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stanciu J, Dolce P, Frenette C, Roy M, Kouider L, Longtin Y
Antimicrob Steward Healthc Epidemiol . 2025 Mar; 5(1):e63. PMID: 40026774
Objective: To develop and validate an automated surveillance system for healthcare-associated infections (HA-CDI). Design: Multicenter cohort study. Setting: 16 acute care hospitals. Patients: Patients admitted to participating hospitals between 2013...
2.
Zhou Z, Silva A, Cannon K, Chow B, Comeau J, Ellis C, et al.
Infect Control Hosp Epidemiol . 2024 Dec; :1-4. PMID: 39696922
Evidence-based insertion and maintenance bundles are effective in reducing the incidence of central line-associated bloodstream infections (CLABSI) in intensive care unit (ICU) settings. We studied the adoption and compliance of...
3.
Lee D, McGill E, Pelude L, Mitchell R, Comeau J, Frenette C, et al.
Antimicrob Steward Healthc Epidemiol . 2024 Oct; 4(1):e175. PMID: 39450098
Objective: This study describes trends in COVID-19 hospitalizations and healthcare-associated (HA) COVID-19 in Canada among pediatric (age <18 years) patients during pre-Omicron and Omicron-dominant periods. Design: Prospective surveillance for COVID-19...
4.
Couture S, Frenette C, Schiller I, Alfaro R, Dendukuri N, Thirion D, et al.
Antimicrob Steward Healthc Epidemiol . 2024 Jun; 4(1):e99. PMID: 38836044
Objective: To describe the epidemiology of healthcare-associated infection (HA-CDI) in two Québec hospitals in Canada following the 2003 epidemic and to evaluate the impact of antibiotic stewardship on the incidence...
5.
Gilca R, Amini R, Carazo S, Doggui R, Frenette C, Boivin G, et al.
JMIR Public Health Surveill . 2024 May; 10():e40792. PMID: 38709551
Background: A comprehensive description of the combined effect of SARS-CoV-2 and respiratory viruses other than SARS-CoV-2 (ORVs) on acute respiratory infection (ARI) hospitalizations is lacking. Objective: This study aimed to...
6.
Mitchell R, Lee D, Pelude L, Comeau J, Conly J, Ellis C, et al.
Can Commun Dis Rep . 2024 Mar; 49(7-8):351-357. PMID: 38455882
Background: Recent studies have demonstrated the effectiveness of nirmatrelvir-ritonavir in reducing the risk of progression to severe disease among outpatients with mild to moderate coronavirus disease 2019 (COVID-19); however, data...
7.
Arsenault C, Harel J, Doualla-Bell F, Cavayas Y, Marchand-Senecal X, Frenette C, et al.
Can Commun Dis Rep . 2024 Mar; 49(7-8):314-319. PMID: 38455880
Background: is a non-fermenting, gram-negative bacteria that has previously been implicated in multiple nosocomial outbreaks through the use of contaminated medical devices and substances. This article reports on an outbreak...
8.
Qaddoura A, Bartoszko J, Mitchell R, Frenette C, Johnston L, Mertz D, et al.
J Assoc Med Microbiol Infect Dis Can . 2024 Jan; 8(4):272-282. PMID: 38250620
Background: Extracorporeal membrane oxygenation (ECMO) for COVID-19 across Canada has not been well-described. We studied trends for patients with COVID-19-related acute respiratory distress syndrome who received ECMO. Methods: Multicentre retrospective...
9.
Thomas S, Tropper D, Knight B, Sheppard D, Lary T, Mackenzie J, et al.
Can Commun Dis Rep . 2024 Jan; 48(11-12):559-570. PMID: 38222826
Background: The availability of national data on the prevalence of antimicrobial resistant infections in smaller, community, northern and rural acute care hospitals is limited. The objective of this article is...
10.
Mitchell R, Cayen J, Thampi N, Frenette C, Bartoszko J, Choi K, et al.
JAMA Netw Open . 2023 Apr; 6(4):e239050. PMID: 37079304
Importance: Trends in COVID-19 severe outcomes have significant implications for the health care system and are key to informing public health measures. However, data summarizing trends in severe outcomes among...